Good news for the injured.. A new American drug delays the development of diabetes and makes patients need insulin

Today, Friday, the US Food and Drug Administration approved the first drug to delay the progression of type 1 diabetes. Teplizumab targets the autoimmune problems that cause T1D type 1 diabetes, rather than its symptoms. On the importance of the drug, Dr. John Sharets, director of the Division of Diabetes, Lipid Disorders and Obesity at … Read more